{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-049103","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2026-07-22T10:58:24+00:00","discovered_at":"2026-07-22T11:00:00.279573+00:00","generated_at":"2026-07-22T11:00:05.454990+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BD EVP Mike Garrison to retire Oct. 2, 2026; BioPharma Systems to report directly to CEO","bullets":["Michael D. Garrison, EVP and President of Medical Essentials and BioPharma Systems, will retire effective Oct. 2, 2026.","Garrison will remain in his role through the end of the fiscal year to support transition.","A comprehensive search is underway for the next President of Medical Essentials.","BioPharma Systems segment will report directly to Chairman, CEO and President Tom Polen, streamlining the operating model.","Garrison spent over 20 years at BD, holding leadership roles including president of Medical segment and Medication Management Solutions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-049103","json":"https://secwatch.observer/filing/0001628280-26-049103.json","markdown":"https://secwatch.observer/filing/0001628280-26-049103.md","text":"https://secwatch.observer/filing/0001628280-26-049103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/0001628280-26-049103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/bdx-20260719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T11:00:05.454990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}